(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Clinical trial NCT04996875 · RECRUITING

Trial details

NCT number: NCT04996875
Sponsor: Cogent Biosciences, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Systemic Mastocytosis (AdvSM)SM With an Associated Hematologic Neoplasm (SM-AHN)Mast Cell Leukemia (MCL)Aggressive Systemic Mastocytosis (ASM)

Start date: 2021-11-09
Primary completion: 2025-09-19
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.